The use of the combined vector vaccine GamCOVID-Vac (Sputnik V) in patients with immuno-inflammatory rheumatic diseases: safety issues-news
The aim of the study was to assess the safety of the combined vector vaccine Gam-COVID-Vac (Sputnik V) and to determine the risk factors for the development of adverse events in patients with immuno-inflammatory rheumatic diseases (IIRD). Patients and methods. A single-stage study of patients with I...
Saved in:
| Main Authors: | A. N. Kulikov, N. V. Muravyeva, B. S. Belov, S. I. Glukhova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2023-06-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/3354 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety of Gam-COVID-Vac (Sputnik V) Combined Vector Vaccine in Patients With Immunoinflammatory Rheumatic Diseases: Preliminary Data
by: A. N. KULIKOV, et al.
Published: (2022-11-01) -
Immunogenicity evaluation of Gam-COVID-Vac (Sputnik V)
by: I. A. Kirillov, et al.
Published: (2022-12-01) -
Efficacy, Immunogenicity, and Safety of the Combined Vector Vaccine Gam-COVID-Vac in Patients with Rheumatic Diseases
by: A. N. Kulikov, et al.
Published: (2024-11-01) -
Thrombosis in unvaccinated and Gam-COVID-Vac-vaccinated patients with COVID-19
by: A. G. Moiseeva, et al.
Published: (2022-08-01) -
Incidence of COVID-19 among Vaccinated with Sputnik V and CoviVac Vaccines (Results of the Telephone Survey for the Epidemic Season 2021–2022 in St. Petersburg)
by: M. K. Erofeeva, et al.
Published: (2024-01-01)